Top 5 Takeaways Investigation and Findings: Between October 2021 and February 2022, nine pediatric patients were identified with severe hepatitis of unknown etiology and concomitant adenovirus infection in Alabama. Clinical

Top 5 Takeaways High Effectiveness of Nirsevimab: Nirsevimab demonstrated a 90% effectiveness in preventing RSV-associated hospitalization among infants in their first RSV season. Median Time to Symptom Onset: The median